← Leaderboards
Sarah A Holstein
University Of Iowa
$5,326,908
Attributed
$7,040,197
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,040,197 · 5
By mechanism
R01$3,782,152 · 2
U54$2,774,821 · 1
P30$483,224 · 2
Top collaborators
- David F Wiemer6 shared
- Aaron M. Mohs5 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsDesignMultiple MyelomaTranslational Research ProgramInter-InstitutionalTranslational ResearchResourcesNebraskaProgramsResearch PersonnelIntellectual PropertyAwardTechnologyBaseClinicNovel StrategiesCollaborationsStructureEvaluationPreclinical StudyFundingFacultyHyaluronic AcidTranslations
Grant awards (20)
Pilot Projects Program$598,280
U54 · FY2025 · GM · contact PI
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma$503,088
R01 · FY2025 · CA · contact PI
Targets, Modulators and Delivery Program$102,781
P30 · FY2025 · CA · contact PI
Pilot Projects Program$562,507
U54 · FY2024 · GM · contact PI
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma$477,934
R01 · FY2024 · CA · contact PI
Targets, Modulators and Delivery Program$95,177
P30 · FY2024 · CA · contact PI
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma$493,027
R01 · FY2023 · CA · contact PI
Pilot Projects Program$419,425
U54 · FY2023 · GM · contact PI
Targets, Modulators and Delivery Program$95,175
P30 · FY2023 · CA · contact PI
Pilot Projects Program$598,278
U54 · FY2022 · GM · contact PI
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma$492,732
R01 · FY2022 · CA · contact PI
Targets, Modulators and Delivery Program$95,175
P30 · FY2022 · CA · contact PI
Pilot Projects Program$596,331
U54 · FY2021 · GM · contact PI
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma$515,150
R01 · FY2021 · CA · contact PI
Targets, Modulators and Delivery Program$94,916
P30 · FY2021 · CA · contact PI
Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma$216,584
R01 · FY2016 · CA · contact PI
Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma$117,336
R01 · FY2016 · CA · contact PI
Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma$333,983
R01 · FY2015 · CA · contact PI
Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma$341,343
R01 · FY2014 · CA · contact PI
Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma$290,975
R01 · FY2013 · CA · contact PI